GCM
ABBV icon

Galibier Capital Management’s AbbVie ABBV Stock Holding History

Galibier Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,512
Closed -$1.18M – 39
2020
Q3 		$1.18M Hold
13,512
– – 0.28% 22
2020
Q2 		$1.33M Sell
13,512
-1,500
-10% -$132K 0.42% 21
2020
Q1 		$1.14M Sell
15,012
-1,091
-7% -$92.9K 0.5% 20
2019
Q4 		$1.43M Sell
16,103
-174,079
-92% -$14.5M 0.45% 22
2019
Q3 		$14.4M Buy
+190,182
New +$13M 5.73% 7

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Galibier Capital Management's ABBV Position: Q4 2020 in Review

Galibier Capital Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 13,512 shares — an estimated $1.18M sold.

Galibier Capital Management first reported a position in ABBV in Q3 2019 and held it in 5 quarters. The position peaked at $14.4M in Q3 2019. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Galibier Capital Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • Galibier Capital Management sold 13,512 AbbVie shares in Q4 2020, an estimated $1.18M.
  • Galibier Capital Management first reported a position in AbbVie in Q3 2019 and held it in 5 quarters.
  • Galibier Capital Management's AbbVie position peaked at $14.4M in Q3 2019.
  • 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Galibier Capital Management's 13F filing for Q4 2020, filed 19 Jan 2021.